SLS - Sellas Life Sciences Group Inc

https://www.sellaslifesciences.com

Buy Momentum: Bearish

Recent News

SELLAS Life Sciences Group ( SLS ) Upgraded to Buy: What Does It Mean for the Stock? ( Revised )

Zacks Commentary • 1 month, 2 weeks ago • score: 0.34

SELLAS Life Sciences Group (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Neutral

SELLAS Life Sciences to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase

GlobeNewswire • 3 months, 3 weeks ago • score: 0.02

NEW YORK, May 20, 2025 ( GLOBE NEWSWIRE ) -- SELLAS Life Sciences Group, Inc. ( NASDAQ: SLS ) ( "SELLAS'' or the "Company" ) , a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Dr. Angelos ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

SELLAS Life Sciences Group, Inc., an advanced-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for various indications of cancer in the United States. The company is headquartered in New York, New York.

52W High

$2.27

52W Low

$0.77

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

2.54

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-1.71

EV/Revenue (<3 favorable)

20.84

P/S (TTM) (<3 favorable)

26.90

P/B (<3 favorable)

7.69

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

0.32%

Institutions (25–75% balanced)

25.55%

Shares Outstanding

105,297,000

Float

104,976,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

900,000

EPS (TTM)

-0.30

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-1.81%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.83

Momentum

Bearish momentum

Value

0.0454

0.0385

Trend

Rising

Signal Cross

No cross

As of

Sep. 05, 2025